Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: ganaxolone

August 12, 2021 Drug delivery / Pharma applications

Marinus Pharmaceuticals and Orion Corporation agree on Commercialization of SBECD-enabled Ganaxolone

Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, announced that

Continue reading

January 14, 2021 Drug delivery / Pharma applications

Marinus Pharmaceuticals Receives Positive Response from FDA on Sufficiency of One Phase 3 Clinical Trial for Filing of New Drug Application (NDA) for the Use of SBECD-enabled Ganaxolone in CDKL5 Deficiency Disorder (CDD)

Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders,

Continue reading

December 11, 2020 Drug delivery / Pharma applications

Marinus Pharmaceuticals Provides SBECD-enabled Ganaxolone Clinical Data

Marinus Pharmaceuticals, Inc., a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders, announced it

Continue reading

September 17, 2020 Pharma applications

Marinus Awarded BARDA Contract to Develop SBECD-enabled Ganaxolone for Treatment of Refractory Status Epilepticus

Marinus Pharmaceuticals, a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders, announced it has

Continue reading

December 19, 2019 Drug delivery / Pharma applications

Marinus Data from SBECD-enabled Ganaxolone Phase 2 Trial in Refractory Status Epilepticus

Marinus Pharmaceuticals, Inc. a pharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy, depression and other neuropsychiatric

Continue reading

October 3, 2019 Pharma applications

Positive Results With SBECD-enabled Ganaxolone in Phase 2 Refractory Status Epilepticus Trial

Marinus Pharmaceuticals, a pharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy, depression and other neuropsychiatric disorders,

Continue reading

Recent Posts

  • HPBCD beads for drug delivery
  • FDA Clears Cyclarity’s UDP-003 Trial for Heart Disease
  • Special issue: Cyclodextrin‑Based Advanced Formulations
  • Grafted β-Cyclodextrin Copolymers as Superplasticizing Admixtures for Cement Mortar
  • Fast-Dissolving Cyclodextrin Nanofibers for Pain Relief

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (28)
  • Analysis (75)
  • CD as API (362)
  • CD derivatives (446)
  • Cosmetics and toilettry (55)
  • Diagnosis (15)
  • Drug delivery (835)
  • E-ducation (64)
  • Environmental (144)
  • Events (243)
  • Food (239)
  • Gene delivery (22)
  • Household products (6)
  • In Hungarian (4)
  • Life sciences (46)
  • Non-pharma applications (429)
  • Other industrial use (115)
  • Pharma applications (1,245)
  • Supramolecular systems (45)
  • Uncategorized (178)

Top Posts

  • HPBCD beads for drug delivery
  • FDA Clears Cyclarity’s UDP-003 Trial for Heart Disease
  • Obituary for Prof. Dr.-Ing. Wolfram Saenger
  • MIT scientists filed patent for HPBCD treatment in Alzheimer's disease
  • Characterization of the substitution pattern of 2-hydroxypropyl-β-cyclodextrin using NMR spectroscopy
  • Why deliver a statin in form of inclusion complex with hydrophilic cyclodextrin?
  • Studies on Sleep-Deprived Animals Reveal HPBCD’s Role in Restoring Normal Neuronal Function
  • Effects of water matrix constituents on micropollutant removal by activated carbon and b-cyclodextrin polymer adsorbents
  • Green Extraction Techniques of Bioactive Compounds: A State-of-the-Art Review
  • 16th Central European Symposium on Pharmaceutical Technology (CESPT 2027)

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,472 other subscribers
Loading Comments...